These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Elbaz O; Budel LM; Hoogerbrugge H; Touw IP; Delwel R; Mahmoud LA; Löwenberg B Blood; 1991 Mar; 77(5):989-95. PubMed ID: 1825289 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW Blood; 1988 Nov; 72(5):1504-11. PubMed ID: 2460153 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3. Jacobsen SE; Ruscetti FW; Roberts AB; Keller JR J Immunol; 1993 Nov; 151(9):4534-44. PubMed ID: 8409417 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody against the common beta subunit (beta c) of the human interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor receptors shows upregulation of beta c by IL-1 and tumor necrosis factor-alpha. Watanabe Y; Kitamura T; Hayashida K; Miyajima A Blood; 1992 Nov; 80(9):2215-20. PubMed ID: 1421392 [TBL] [Abstract][Full Text] [Related]
16. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of differential inhibition of factor-dependent cell proliferation by transforming growth factor-beta 1: selective uncoupling of FMS from MYC. Chen AR; Rohrschneider LR Blood; 1993 May; 81(10):2539-46. PubMed ID: 8490168 [TBL] [Abstract][Full Text] [Related]
18. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha. Jacobsen SE; Veiby OP; Myklebust J; Okkenhaug C; Lyman SD Blood; 1996 Jun; 87(12):5016-26. PubMed ID: 8652814 [TBL] [Abstract][Full Text] [Related]
19. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells. Lotem J; Sachs L Blood; 1990 Oct; 76(7):1315-22. PubMed ID: 2207308 [TBL] [Abstract][Full Text] [Related]
20. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Matsunaga T; Hirayama F; Yonemura Y; Murray R; Ogawa M Blood; 1998 Aug; 92(3):901-7. PubMed ID: 9680358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]